These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14696107)

  • 1. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models.
    Peer D; Margalit R
    Int J Cancer; 2004 Feb; 108(5):780-9. PubMed ID: 14696107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models.
    Peer D; Margalit R
    Neoplasia; 2004; 6(4):343-53. PubMed ID: 15256056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LHRH Targeted Chonderosomes of Mitomycin C in Breast Cancer: An
    Varshosaz J; Sarrami N; Aghaei M; Aliomrani M; Azizi R
    Anticancer Agents Med Chem; 2019; 19(11):1405-1417. PubMed ID: 30987576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
    Eliaz RE; Szoka FC
    Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex.
    Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z
    Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.
    Bachar G; Cohen K; Hod R; Feinmesser R; Mizrachi A; Shpitzer T; Katz O; Peer D
    Biomaterials; 2011 Jul; 32(21):4840-8. PubMed ID: 21482433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
    Qu QL; Zhang YG; Yang LZ; Sun L
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
    Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
    Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages and safety of local treatment with MMC/Beriplast P for cancer tumors.
    Matsuoka H; Yano K; Katsuta Y; Morita M; Kounoe S; Seo Y; Saito T; Tomoda H
    Cancer Chemother Pharmacol; 1996; 38(6):508-12. PubMed ID: 8823491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
    Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
    ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia.
    Takeuchi H; Baba H; Maehara Y; Sugimachi K; Newman RA
    Cancer Chemother Pharmacol; 1996; 38(1):1-8. PubMed ID: 8603441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes.
    Peer D; Margalit R
    Arch Biochem Biophys; 2000 Nov; 383(2):185-90. PubMed ID: 11185552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of IgG-Fc-mitomycin C conjugate on cancer cells].
    Baba E
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):271-81. PubMed ID: 8641681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
    Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
    Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.